7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Early cancer detection has significant clinical value, but there remains no single method that can comprehensively identify multiple types of early-stage cancer. Here, we report the diagnostic accuracy of simultaneous detection of 6 types of early-stage cancers (lung, breast, colon, liver, pancreas, and stomach) by analyzing surface-enhanced Raman spectroscopy profiles of exosomes using artificial intelligence in a retrospective study design. It includes classification models that recognize signal patterns of plasma exosomes to identify both their presence and tissues of origin. Using 520 test samples, our system identified cancer presence with an area under the curve value of 0.970. Moreover, the system classified the tumor organ type of 278 early-stage cancer patients with a mean area under the curve of 0.945. The final integrated decision model showed a sensitivity of 90.2% at a specificity of 94.4% while predicting the tumor organ of 72% of positive patients. Since our method utilizes a non-specific analysis of Raman signatures, its diagnostic scope could potentially be expanded to include other diseases.

          Abstract

          Early detection of multiple cancers through a single method could be clinically important. Here the authors report the diagnostic performance for early detection for multiple cancers using surface-enhanced Raman spectroscopy (SERS) profiles of exosomes from a single blood test and artificial intelligence in a retrospective study design.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          Deep learning.

          Deep learning allows computational models that are composed of multiple processing layers to learn representations of data with multiple levels of abstraction. These methods have dramatically improved the state-of-the-art in speech recognition, visual object recognition, object detection and many other domains such as drug discovery and genomics. Deep learning discovers intricate structure in large data sets by using the backpropagation algorithm to indicate how a machine should change its internal parameters that are used to compute the representation in each layer from the representation in the previous layer. Deep convolutional nets have brought about breakthroughs in processing images, video, speech and audio, whereas recurrent nets have shone light on sequential data such as text and speech.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Cancer statistics, 2022

            Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes. Incidence data (through 2018) were collected by the Surveillance, Epidemiology, and End Results program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2019) were collected by the National Center for Health Statistics. In 2022, 1,918,030 new cancer cases and 609,360 cancer deaths are projected to occur in the United States, including approximately 350 deaths per day from lung cancer, the leading cause of cancer death. Incidence during 2014 through 2018 continued a slow increase for female breast cancer (by 0.5% annually) and remained stable for prostate cancer, despite a 4% to 6% annual increase for advanced disease since 2011. Consequently, the proportion of prostate cancer diagnosed at a distant stage increased from 3.9% to 8.2% over the past decade. In contrast, lung cancer incidence continued to decline steeply for advanced disease while rates for localized-stage increased suddenly by 4.5% annually, contributing to gains both in the proportion of localized-stage diagnoses (from 17% in 2004 to 28% in 2018) and 3-year relative survival (from 21% to 31%). Mortality patterns reflect incidence trends, with declines accelerating for lung cancer, slowing for breast cancer, and stabilizing for prostate cancer. In summary, progress has stagnated for breast and prostate cancers but strengthened for lung cancer, coinciding with changes in medical practice related to cancer screening and/or treatment. More targeted cancer control interventions and investment in improved early detection and treatment would facilitate reductions in cancer mortality.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

              ABSTRACT The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points.
                Bookmark

                Author and article information

                Contributors
                kimhyunkoo@korea.ac.kr
                yeonhochoi@korea.ac.kr
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                24 March 2023
                24 March 2023
                2023
                : 14
                : 1644
                Affiliations
                [1 ]EXoPERT Corporation, Seoul, 02580 Republic of Korea
                [2 ]GRID grid.411134.2, ISNI 0000 0004 0474 0479, Department of Thoracic and Cardiovascular Surgery, College of Medicine, , Korea University Guro Hospital, ; Seoul, 08308 Republic of Korea
                [3 ]GRID grid.222754.4, ISNI 0000 0001 0840 2678, Korea Artificial Organ Center, Korea University, ; Seoul, 02841 Republic of Korea
                [4 ]GRID grid.222754.4, ISNI 0000 0001 0840 2678, Division of Hematology-Oncology, Department of Internal Medicine, , Korea University College of Medicine, ; Seoul, 02841 Republic of Korea
                [5 ]GRID grid.412480.b, ISNI 0000 0004 0647 3378, Division of Thoracic Surgery, Department of Thoracic and Cardiovascular Surgery, , Seoul National University Bundang Hospital, ; Seongnam, 13620 Republic of Korea
                [6 ]GRID grid.222754.4, ISNI 0000 0001 0840 2678, Department of Biomedical Sciences, , College of Medicine, Korea University, ; 02841 Seoul, Republic of Korea
                [7 ]GRID grid.222754.4, ISNI 0000 0001 0840 2678, School of Biomedical Engineering, Korea University, ; Seoul, 02841 Republic of Korea
                [8 ]GRID grid.222754.4, ISNI 0000 0001 0840 2678, Department of Biomedical Engineering, , Korea University, ; Seoul, 02841 Republic of Korea
                [9 ]GRID grid.222754.4, ISNI 0000 0001 0840 2678, Interdisciplinary Program in Precision Public Health, , Korea University, ; 02841 Seoul, Republic of Korea
                Author information
                http://orcid.org/0000-0001-8590-3468
                http://orcid.org/0000-0003-0792-142X
                http://orcid.org/0000-0001-7604-4729
                http://orcid.org/0000-0003-2018-3599
                Article
                37403
                10.1038/s41467-023-37403-1
                10039041
                36964142
                f2cf3afc-e70d-4c5e-b0c6-cdb2550e4c4b
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 27 September 2022
                : 16 March 2023
                Funding
                Funded by: Funder: Seoul Business Agency (SBA) Grant number: BT210040
                Funded by: Funder: Korea Medical Device Development Fund Grant number: RS-2020-KD000094
                Categories
                Article
                Custom metadata
                © The Author(s) 2023

                Uncategorized
                diagnosis,cancer screening,biomedical engineering,biosensors
                Uncategorized
                diagnosis, cancer screening, biomedical engineering, biosensors

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content330

                Cited by44

                Most referenced authors5,136